Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Maria Ruiz-Iriondo, Karmele Salaberría, Rocio Polo-López, Álvaro Iruin & Enrique Echeburúa. (2020) Improving clinical symptoms, functioning, and quality of life in chronic schizophrenia with an integrated psychological therapy (IPT) plus emotional management training (EMT): A controlled clinical trial. Psychotherapy Research 30:8, pages 1026-1038.
Read now
Read now
Lyang Huh & Bong Ju Lee. (2019) Comparison of long-term efficacy and safety of blonanserin treatment in individuals with first-episode and relapsed schizophrenia: a 3-year retrospective study. Psychiatry and Clinical Psychopharmacology 29:4, pages 399-406.
Read now
Read now
Kristyna Vrbova, Jan Prasko, Michaela Holubova, Dana Kamaradova, Marie Ociskova, Marketa Marackova, Klara Latalova, Ales Grambal, Milos Slepecky & Marta Zatkova. (2016) Self-stigma and schizophrenia: a cross-sectional study. Neuropsychiatric Disease and Treatment 12, pages 3011-3020.
Read now
Read now
Jenifer L. Vohs, Sunita George, Bethany L. Leonhardt & Paul H. Lysaker. (2016) An integrative model of the impairments in insight in schizophrenia: emerging research on causal factors and treatments. Expert Review of Neurotherapeutics 16:10, pages 1193-1204.
Read now
Read now
José Manuel Olivares, Köksal Alptekin, Jean-Michel Azorin, Fernando Cañas, Vincent Dubois, Robin Emsley, Philip Gorwood, Peter M Haddad, Dieter Naber, George Papageorgiou, Miquel Roca, Pierre Thomas, Guadalupe Martinez & Andreas Schreiner. (2013) Psychiatrists’ awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa. Patient Preference and Adherence 7, pages 121-132.
Read now
Read now
Paul H Lysaker, Jen Vohs, Jaclyn D Hillis, Marina Kukla, Raffaele Popolo, Giampaolo Salvatore & Giancarlo Dimaggio. (2013) Poor insight into schizophrenia: contributing factors, consequences and emerging treatment approaches. Expert Review of Neurotherapeutics 13:7, pages 785-793.
Read now
Read now
Esteban Medina, Joan Salvà, Rubén Ampudia, Jorge Maurino & Juan Larumbe. (2012) Short-term clinical stability and lack of insight are associated with a negative attitude towards antipsychotic treatment at discharge in patients with schizophrenia and bipolar disorder. Patient Preference and Adherence 6, pages 623-629.
Read now
Read now
CynthiaZ. Burton, Lea Vella & ElizabethW. Twamley. (2011) Clinical and Cognitive Insight in a Compensatory Cognitive Training Intervention. American Journal of Psychiatric Rehabilitation 14:4, pages 307-326.
Read now
Read now
PaulH. Lysaker, MollyA. Erickson, Benjamin Buck, KellyD. Buck, Kyle Olesek, MeganL. A. Grant, Giampaolo Salvatore, Raffaele Popolo & Giancarlo Dimaggio. (2011) Metacognition and social function in schizophrenia: Associations over a period of five months. Cognitive Neuropsychiatry 16:3, pages 241-255.
Read now
Read now
Katerine Osatuke, Mary Reid, WilliamB. Stiles, JohnW. Kasckow, Sidney Zisook & Somaia Mohamed. (2011) Narrative evolution and assimilation of problematic experiences in a case of pharmacotherapy for schizophrenia. Psychotherapy Research 21:1, pages 41-53.
Read now
Read now
Articles from other publishers (58)
Antonino Messina, Giuseppe Cuccì, Caterina Crescimanno & Maria Salvina Signorelli. (2023) Clinical anatomy of the precuneus and pathogenesis of the schizophrenia. Anatomical Science International 98:4, pages 473-481.
Crossref
Crossref
Paul H. Lysaker, Peter J. Weiden, Xiaowu Sun, Amy K. O’Sullivan & Joseph P. McEvoy. (2022) Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial. BMC Psychiatry 22:1.
Crossref
Crossref
Mojtaba Habibi Asgarabad, Seyed Ruhollah Hosseini, Pardis Salehi Yegaei, Shahram Moradi & Paul H. Lysaker. (2022) Psychopathology and Poor Clinical Insight in Psychotic Patients. Journal of Nervous & Mental Disease 210:7, pages 532-540.
Crossref
Crossref
Hsue-Wei Chan, Chin-Yu Huang & Yung-Chieh Yen. (2021) Clinical outcomes of paliperidone long-acting injection in patients with schizophrenia: a 1-year retrospective cohort study. BMC Psychiatry 21:1.
Crossref
Crossref
John D. Little. (2020) In schizophrenia, are lack of capacity and lack of insight more usefully understood as anosognosia?. Australasian Psychiatry 29:3, pages 346-348.
Crossref
Crossref
John D Little & Elliot Bell. (2020) Anosognosia and schizophrenia – a reminder. Australasian Psychiatry 29:3, pages 344-345.
Crossref
Crossref
Bethany L. Leonhardt, Jenifer L. Vohs, Lisa A. Bartolomeo, Andrew Visco, William P. Hetrick, Amanda R. Bolbecker, Alan Breier, Paul H. Lysaker & Brian F. O’Donnell. (2019) Relationship of Metacognition and Insight to Neural Synchronization and Cognitive Function in Early Phase Psychosis. Clinical EEG and Neuroscience 51:4, pages 259-266.
Crossref
Crossref
Guyonne Rogier, Andrea Caputo, Viviana Langher, Paul H. Lysaker, Giancarlo Dimaggio & Patrizia Velotti. (2019) Giving a Voice to Gambling Addiction: Analysis of Personal Narratives. Culture, Medicine, and Psychiatry 44:2, pages 159-174.
Crossref
Crossref
Steven Jong, Ilanit Hasson‐Ohayon, Rozanne J.M. Donkersgoed, Marieke E. Timmerman, Mark Gaag, Andre Aleman, G.H. Marieke Pijnenborg & Paul H. Lysaker. (2019) Predicting therapy success from the outset: The moderating effect of insight into the illness on metacognitive psychotherapy outcome among persons with schizophrenia. Clinical Psychology & Psychotherapy 26:6, pages 650-660.
Crossref
Crossref
C. Bouvet, C. Naudin & J. Zajac. (2019) Le concept d’insight narratif chez les personnes souffrant de schizophrénie : une revue systématique de la littérature. L'Encéphale 45:3, pages 256-262.
Crossref
Crossref
G.H.M. Pijnenborg, A.E. de Vos, M.E. Timmerman, M. Van der Gaag, B.E. Sportel, J. Arends, E.M. Koopmans, L. Van der Meer & A. Aleman. (2019) Social cognitive group treatment for impaired insight in psychosis: A multicenter randomized controlled trial. Schizophrenia Research 206, pages 362-369.
Crossref
Crossref
Tae Yong KimJun Gee KimChul Kwon Kim. (2019) The Insight Paradox among Outpatients with Schizophrenia. Korean Journal of Schizophrenia Research 22:2, pages 56.
Crossref
Crossref
S. de Jong, R. J. M. van Donkersgoed, M. E. Timmerman, M. aan het Rot, L. Wunderink, J. Arends, M. van Der Gaag, A. Aleman, P. H. Lysaker & G. H. M. Pijnenborg. (2018) Metacognitive reflection and insight therapy (MERIT) for patients with schizophrenia. Psychological Medicine 49:2, pages 303-313.
Crossref
Crossref
Ilanit Hasson-Ohayon. (2018) Overlap and distinction between measures of insight and self-stigma. Psychiatry Research 266, pages 47-64.
Crossref
Crossref
Y.-J. Lien, H.-A. Chang, Y.-C. Kao, N.-S. Tzeng, C.-W. Lu & C.-H. Loh. (2016) Insight, self-stigma and psychosocial outcomes in Schizophrenia: a structural equation modelling approach. Epidemiology and Psychiatric Sciences 27:2, pages 176-185.
Crossref
Crossref
Tobias Feldhaus, Sebastian Falke, Lara von Gruchalla, Birgit Maisch, Christina Uhlmann, Eva Bock & Rebekka Lencer. (2018) The impact of self-stigmatization on medication attitude in schizophrenia patients. Psychiatry Research 261, pages 391-399.
Crossref
Crossref
Patricia Ponce de León, Philip Gerretsen, Parita Shah, Ricardo Saracco-Alvarez, Ariel Graff-Guerrero & Ana Fresán. (2018) Cross-cultural psychometric assessment of the VAGUS insight into psychosis scale – Spanish version. Psychiatry Research 259, pages 450-454.
Crossref
Crossref
S. Potvin, G. Aubin & E. Stip. (2017) L’insight neurocognitif dans la schizophrénie. L'Encéphale 43:1, pages 15-20.
Crossref
Crossref
Bethany L. Leonhardt, Kelsey Benson, Sunita George, Kelly D. Buck, Rheannan Shaieb & Jenifer L. Vohs. (2016) Targeting Insight in First Episode Psychosis: A Case Study of Metacognitive Reflection Insight Therapy (MERIT). Journal of Contemporary Psychotherapy 46:4, pages 207-216.
Crossref
Crossref
Lauren Luther, Michelle P. Salyers, Ruth L. Firmin, Matthew P. Marggraf, Beshaun Davis & Kyle S. Minor. (2016) Additional support for the cognitive model of schizophrenia: evidence of elevated defeatist beliefs in schizotypy. Comprehensive Psychiatry 68, pages 40-47.
Crossref
Crossref
Ziyan Xu, Mario Müller, Karsten Heekeren, Anastasia Theodoridou, Sibylle Metzler, Diane Dvorsky, Nathalie Oexle, Susanne Walitza, Wulf Rössler & Nicolas Rüsch. (2016) Pathways between stigma and suicidal ideation among people at risk of psychosis. Schizophrenia Research 172:1-3, pages 184-188.
Crossref
Crossref
Kevin K.S. Chan. (2016) Associations of symptoms, neurocognition, and metacognition with insight in schizophrenia spectrum disorders. Comprehensive Psychiatry 65, pages 63-69.
Crossref
Crossref
Cynthia O. Siu, Philip D. Harvey, Ofer Agid, Mary Waye, Carla Brambilla, Wing-Kit Choi & Gary Remington. (2015) Insight and subjective measures of quality of life in chronic schizophrenia. Schizophrenia Research: Cognition 2:3, pages 127-132.
Crossref
Crossref
R. Jørgensen, R.W. Licht, P.H. Lysaker, P. Munk-Jørgensen, K.D. Buck, S.O.W. Jensen, L. Hansson & V. Zoffmann. (2020) Effects on cognitive and clinical insight with the use of Guided Self-Determination in outpatients with schizophrenia: A randomized open trial. European Psychiatry 30:5, pages 655-663.
Crossref
Crossref
Jenifer L. Vohs, Paul H. Lysaker, Emily Liffick, Michael M. Francis, Bethany L. Leonhardt, Alison James, Kelly D. Buck, Jay A. Hamm, Kyle S. Minor, Nikki Mehdiyoun & Alan Breier. (2015) Metacognitive Capacity as a Predictor of Insight in First-Episode Psychosis. Journal of Nervous & Mental Disease 203:5, pages 372-378.
Crossref
Crossref
Doreen M. Olvet, Ricardo E. Carrión, Andrea M. Auther & Barbara A. Cornblatt. (2015) Self-awareness of functional impairment in individuals at clinical high-risk for psychosis. Early Intervention in Psychiatry 9:2, pages 100-107.
Crossref
Crossref
Lizzette Gómez-de-Regil. (2015) Insight and illness perception in Mexican patients with psychosis. Schizophrenia Research: Cognition 2:1, pages 33-38.
Crossref
Crossref
Lydia P. Ogden. (2014) “My Life as it is Has Value”. Qualitative Health Research 24:10, pages 1342-1355.
Crossref
Crossref
Linda Pruß, Karl Heinz Wiedl & Manuel Waldorf. (2014) Der Beitrag subjektiver Krankheitsrepräsentationen zur Erklärung beeinträchtigter Krankheitseinsicht bei Schizophrenie. Zeitschrift für Klinische Psychologie und Psychotherapie 43:3, pages 162-170.
Crossref
Crossref
Stéphane Raffard, Catherine Bortolon, Camille Rolland, Delphine Capdevielle, Jean-Philippe Boulenger, Marie-Christine Gely-Nargeot & Yannick Stephan. (2014) Memory self-efficacy in schizophrenia. Schizophrenia Research 156:1, pages 56-59.
Crossref
Crossref
Jesse A. Bastiaens & Smita Agarkar. (2014) A Case Review of Poor Insight in Schizophrenia: How Much Do We Know?. Psychiatric Annals 44:5, pages 207-210.
Crossref
Crossref
M. Cella, S. Swan, E. Medin, C. Reeder & T. Wykes. (2013) Metacognitive awareness of cognitive problems in schizophrenia: exploring the role of symptoms and self-esteem. Psychological Medicine 44:3, pages 469-476.
Crossref
Crossref
Solomon Teferra, Charlotte Hanlon, Teferra Beyero, Lars Jacobsson & Teshome Shibre. (2013) Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers. BMC Psychiatry 13:1.
Crossref
Crossref
Antoon W.B. van Baars, André I. Wierdsma, Michiel W. Hengeveld & Cornelis L. Mulder. (2013) Improved insight affects social outcomes in involuntarily committed psychotic patients: A longitudinal study in the Netherlands. Comprehensive Psychiatry 54:7, pages 873-879.
Crossref
Crossref
Maria Lalova, Franck Baylé, Marie-Laure Grillon, Laëtitia Houet, Elodie Moreau, Francis Rouam, Pascal Cacot & Pascale Piolino. (2013) Mechanisms of insight in schizophrenia and impact of cognitive remediation therapy. Comprehensive Psychiatry 54:4, pages 369-380.
Crossref
Crossref
John Stratton, Philip T. Yanos & Paul Lysaker. (2013) Insight, Neurocognition, and Schizophrenia: Predictive Value of the Wisconsin Card Sorting Test. Schizophrenia Research and Treatment 2013, pages 1-6.
Crossref
Crossref
Carol S. Aneshensel. 2013. Handbook of the Sociology of Mental Health. Handbook of the Sociology of Mental Health
603
620
.
Jose Manuel Montes, Esteban Medina, Manuel Gomez-Beneyto & Jorge Maurino. (2012) A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia. Psychiatry Research 200:2-3, pages 89-95.
Crossref
Crossref
R. Schennach, S. Meyer, F. Seemüller, M. Jäger, M. Schmauss, G. Laux, H. Pfeiffer, D. Naber, L.G. Schmidt, W. Gaebel, J. Klosterkötter, I. Heuser, W. Maier, M.R. Lemke, E. Rüther, S. Klingberg, M. Gastpar, H.-J. Möller & M. Riedel. (2012) Insight in schizophrenia–course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder. European Psychiatry 27:8, pages 625-633.
Crossref
Crossref
Laurent Boyer, Michel Cermolacce, Daniel Dassa, Jessica Fernandez, Mohamed Boucekine, Raphaelle Richieri, Florence Vaillant, Remy Dumas, Pascal Auquier & Christophe Lancon. (2012) Neurocognition, Insight and Medication Nonadherence in Schizophrenia: A Structural Equation Modeling Approach. PLoS ONE 7:10, pages e47655.
Crossref
Crossref
Anna Moriarty, Suzanne Jolley, Margie M. Callanan & Philippa Garety. (2012) Understanding reduced activity in psychosis: the roles of stigma and illness appraisals. Social Psychiatry and Psychiatric Epidemiology 47:10, pages 1685-1693.
Crossref
Crossref
Kevin K.S. Chan & Winnie W.S. Mak. (2012) Shared decision making in the recovery of people with schizophrenia: The role of metacognitive capacities in insight and pragmatic language use. Clinical Psychology Review 32:6, pages 535-544.
Crossref
Crossref
L. Boyer, V. Aghababian, R. Richieri, A. Loundou, R. Padovani, M.C. Simeoni, P. Auquier & C. Lançon. (2012) Insight into illness, neurocognition and quality of life in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 36:2, pages 271-276.
Crossref
Crossref
Alice M. Saperstein, Julie Thysen & Alice Medalia. (2012) The Measure of Insight into Cognition: Reliability and validity of clinician-rated and self-report scales of neurocognitive insight for schizophrenia. Schizophrenia Research 134:1, pages 54-58.
Crossref
Crossref
Yu-Chen Kao, Tzong-Shi Wang, Chien-Wen Lu & Yia-Ping Liu. (2011) Assessing cognitive insight in nonpsychiatric individuals and outpatients with schizophrenia in Taiwan: an investigation using the Beck Cognitive Insight Scale. BMC Psychiatry 11:1.
Crossref
Crossref
Jong-Hoon Kim, Jun-Hyung Ann & Jinyoung Lee. (2011) Insight change and its relationship to subjective well-being during acute atypical antipsychotic treatment in schizophrenia. Journal of Clinical Pharmacy and Therapeutics 36:6, pages 687-694.
Crossref
Crossref
Elisabeth Bacon, Nathalie Huet & Jean-Marie Danion. (2011) Metamemory knowledge and beliefs in patients with schizophrenia and how these relate to objective cognitive abilities. Consciousness and Cognition 20:4, pages 1315-1326.
Crossref
Crossref
Maureen Donohue‐Smith. (2011) Telling the whole story: a conceptual model for analysing the mental illness memoir. Mental Health Review Journal 16:3, pages 138-146.
Crossref
Crossref
Manuel J. Cuesta, Victor Peralta, Maria S. Campos & Elena Garcia-Jalon. (2011) Can insight be predicted in first-episode psychosis patients? A longitudinal and hierarchical analysis of predictors in a drug-naïve sample. Schizophrenia Research 130:1-3, pages 148-156.
Crossref
Crossref
Rosa Ayesa-Arriola, Jose Manuel Rodríguez-Sánchez, Chiara Morelli, Jose María Pelayo-Terán, Rocío Pérez-Iglesias, Ignacio Mata, Obdulia Martínez-Garcia, Gema Pardo-Garcia, Jose L. Vazquez-Barquero & Benedicto Crespo-Facorro. (2011) Insight dimensions in first-episode psychosis patients: clinical, cognitive, pre-morbid and socio-demographic correlates. Early Intervention in Psychiatry 5:2, pages 140-149.
Crossref
Crossref
Paul H. Lysaker, Giancarlo Dimaggio, Kelly D. Buck, Stephanie S. Callaway, Gimapaolo Salvatore, Antonino Carcione, Giuseppe Nicolò & Giovanni Stanghellini. (2011) Poor insight in schizophrenia: links between different forms of metacognition with awareness of symptoms, treatment need, and consequences of illness. Comprehensive Psychiatry 52:3, pages 253-260.
Crossref
Crossref
Matthew M. Kurtz & Arielle Tolman. (2011) Neurocognition, insight into illness and subjective quality-of-life in schizophrenia: What is their relationship?. Schizophrenia Research 127:1-3, pages 157-162.
Crossref
Crossref
Walid El Ansari, Christiane Stock, Ceri Phillips, Andi Mabhala, Mary Stoate, Hamed Adetunji, Pat Deeny, Jill John, Shan Davies, Sian Parke, Xiaoling Hu & Sherrill Snelgrove. (2011) Does the Association between Depressive Symptomatology and Physical Activity Depend on Body Image Perception? A Survey of Students from Seven Universities in the UK. International Journal of Environmental Research and Public Health 8:2, pages 281-299.
Crossref
Crossref
M. S. Campos, E. Garcia-Jalon, J. K. Gilleen, A. S. David, V. Peralta MD & M. J. Cuesta. (2010) Premorbid Personality and Insight in First-Episode Psychosis. Schizophrenia Bulletin 37:1, pages 52-60.
Crossref
Crossref
Michael S. Ritsner & Paul H. Lysaker. 2011. Handbook of Schizophrenia Spectrum Disorders, Volume III. Handbook of Schizophrenia Spectrum Disorders, Volume III
149
171
.
Paul H. Lysaker & Molly A. Erickson. 2011. Handbook of Schizophrenia Spectrum Disorders, Volume III. Handbook of Schizophrenia Spectrum Disorders, Volume III
225
244
.
P.H. Lysaker & M.A. Erickson. (2010) La psychothérapie individuelle de la schizophrénie: mise en perspective de son histoire, de ses développements récents et de ses orientations nouvellesIndividual psychotherapy for schizophrenia: an overview of its history, recent developments and new directions. PSN 8:4, pages 187-196.
Crossref
Crossref
Marjorie Baier. (2010) Insight in Schizophrenia: A Review. Current Psychiatry Reports 12:4, pages 356-361.
Crossref
Crossref